Ascending Dose Study of HU6 in Healthy Volunteers

NCT04463017 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

NASH - Nonalcoholic Steatohepatitis

Interventions

DRUG: HU6

Sponsor

Rivus Pharmaceuticals, Inc.